Shruthi Naik

1.0k total citations
26 papers, 712 citations indexed

About

Shruthi Naik is a scholar working on Genetics, Epidemiology and Animal Science and Zoology. According to data from OpenAlex, Shruthi Naik has authored 26 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 10 papers in Epidemiology and 9 papers in Animal Science and Zoology. Recurrent topics in Shruthi Naik's work include Virus-based gene therapy research (19 papers), Animal Virus Infections Studies (9 papers) and CAR-T cell therapy research (4 papers). Shruthi Naik is often cited by papers focused on Virus-based gene therapy research (19 papers), Animal Virus Infections Studies (9 papers) and CAR-T cell therapy research (4 papers). Shruthi Naik collaborates with scholars based in United States, Germany and Canada. Shruthi Naik's co-authors include Stephen J. Russell, Rebecca A. Nace, Mark J. Federspiel, Glen N. Barber, Kah-Whye Peng, K-W Peng, Lukkana Suksanpaisan, John C. Bell, Anthony Power and Apollina Goel and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shruthi Naik

26 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shruthi Naik United States 14 551 250 219 171 161 26 712
Jacob P. van Vloten Canada 15 234 0.4× 238 1.0× 162 0.7× 99 0.6× 163 1.0× 32 640
Mina Lee Vernon United States 12 207 0.4× 128 0.5× 189 0.9× 74 0.4× 158 1.0× 24 605
Emily V. Mesev United States 6 107 0.2× 131 0.5× 166 0.8× 54 0.3× 106 0.7× 9 521
Anagha P. Phadke United States 10 207 0.4× 152 0.6× 223 1.0× 9 0.1× 118 0.7× 14 527
Sandra Pinkert Germany 19 303 0.5× 82 0.3× 410 1.9× 53 0.3× 171 1.1× 37 819
J. Michael Stolley United States 12 76 0.1× 226 0.9× 197 0.9× 42 0.2× 107 0.7× 17 939
Mauro Di Pilato Spain 12 111 0.2× 268 1.1× 236 1.1× 14 0.1× 158 1.0× 16 818
Yukiharu Sawada Japan 12 375 0.7× 228 0.9× 342 1.6× 24 0.1× 75 0.5× 20 560
Jeremy Juang United States 11 146 0.3× 181 0.7× 330 1.5× 32 0.2× 264 1.6× 12 1.0k
Huaxin Si United States 12 76 0.1× 356 1.4× 113 0.5× 40 0.2× 348 2.2× 17 595

Countries citing papers authored by Shruthi Naik

Since Specialization
Citations

This map shows the geographic impact of Shruthi Naik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shruthi Naik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shruthi Naik more than expected).

Fields of papers citing papers by Shruthi Naik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shruthi Naik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shruthi Naik. The network helps show where Shruthi Naik may publish in the future.

Co-authorship network of co-authors of Shruthi Naik

This figure shows the co-authorship network connecting the top 25 collaborators of Shruthi Naik. A scholar is included among the top collaborators of Shruthi Naik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shruthi Naik. Shruthi Naik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
LeBlanc, Amy K., Christina Mazcko, Nicola J. Mason, et al.. (2025). Comparative oncology in action: vignettes on immunotherapy development. PubMed. 2(1). 5–5. 1 indexed citations
2.
McGarrah, Patrick W., Shruthi Naik, Þorvarður R. Hálfdánarson, et al.. (2024). Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with ipilimumab and nivolumab, in patients with neuroendocrine carcinoma.. Journal of Clinical Oncology. 42(3_suppl). TPS602–TPS602. 1 indexed citations
3.
Robinson, Steven I., et al.. (2024). Translation of oncolytic viruses in sarcoma. SHILAP Revista de lepidopterología. 32(3). 200822–200822. 5 indexed citations
4.
Naik, Shruthi & Luke Russell. (2022). The 13th International Oncolytic Virus Conference: Powerful payloads gain clinical momentum. Molecular Therapy. 30(4). 1361–1363. 4 indexed citations
5.
Naik, Shruthi, Bradley C. Leibovich, Tanner Miest, et al.. (2022). Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma.. Journal of Clinical Oncology. 40(6_suppl). 509–509. 7 indexed citations
6.
Makielski, Kelly M., Lauren J. Mills, Aaron L. Sarver, et al.. (2019). Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review. Veterinary Sciences. 6(2). 48–48. 61 indexed citations
7.
Naik, Shruthi, Amber Miller, Sara D. Allstadt, et al.. (2017). Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer. Molecular Cancer Therapeutics. 17(1). 316–326. 42 indexed citations
8.
Velázquez-Salinas, Lauro, Shruthi Naik, Steven J. Pauszek, et al.. (2017). Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV. PubMed. 28(2). 108–115. 37 indexed citations
9.
Prasad, Shankar, et al.. (2017). Prevalence of self-care practices and assessment of their sociodemographic risk factors among diabetes in the urban slums of Bengaluru. SHILAP Revista de lepidopterología. 6(2). 218–218. 11 indexed citations
10.
Zhang, Lianwen, Lukkana Suksanpaisan, Shruthi Naik, et al.. (2016). Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS. PubMed. 27(3). 111–122. 46 indexed citations
11.
Zhang, Lianwen, Marshall D. Behrens, Rebecca A. Nace, et al.. (2016). Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model. Molecular Therapy. 24(12). 2109–2117. 17 indexed citations
12.
Naik, Shruthi, Sara D. Allstadt, Megan L. Steele, et al.. (2014). Early findings from a comparative oncology study evaluating systemic VSV therapy in client-owned dogs with spontaneous hematologic malignancies. Human Gene Therapy. 25(12). 1 indexed citations
13.
Miller, Amber, Lukkana Suksanpaisan, Shruthi Naik, et al.. (2014). Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy. Molecular Therapy — Oncolytics. 1. 14005–14005. 24 indexed citations
14.
Yarde, Danielle N., Shruthi Naik, Rebecca A. Nace, et al.. (2013). Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV. Cancer Gene Therapy. 20(11). 616–621. 13 indexed citations
15.
Bailey, Kent R., Shruthi Naik, Rebecca A. Nace, et al.. (2013). Mathematical Model for Radial Expansion and Conflation of Intratumoral Infectious Centers Predicts Curative Oncolytic Virotherapy Parameters. PLoS ONE. 8(9). e73759–e73759. 27 indexed citations
16.
LeBlanc, Amy K., Shruthi Naik, Kah-Whye Peng, et al.. (2013). Safety Studies on Intravenous Administration of Oncolytic Recombinant Vesicular Stomatitis Virus in Purpose-Bred Beagle Dogs. PubMed. 24(4). 174–181. 37 indexed citations
17.
Naik, Shruthi, Rebecca A. Nace, Mark J. Federspiel, et al.. (2012). Curative one-shot systemic virotherapy in murine myeloma. Leukemia. 26(8). 1870–1878. 69 indexed citations
18.
Naik, Shruthi, Rebecca A. Nace, Glen N. Barber, & Stephen J. Russell. (2012). Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β. Cancer Gene Therapy. 19(7). 443–450. 71 indexed citations
19.
Naik, Shruthi & Stephen J. Russell. (2009). Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways. Expert Opinion on Biological Therapy. 9(9). 1163–1176. 93 indexed citations
20.
Matsuura, Bunzo, Maoqing Dong, Shruthi Naik, Laurence J. Miller, & Morikazu Onji. (2006). Differential Contributions of Motilin Receptor Extracellular Domains for Peptide and Non-peptidyl Agonist Binding and Activity. Journal of Biological Chemistry. 281(18). 12390–12396. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacob P. van Vloten Breakdown of academic impact, for papers by Mina Lee Vernon Breakdown of academic impact, for papers by Emily V. Mesev Breakdown of academic impact, for papers by Anagha P. Phadke Breakdown of academic impact, for papers by Sandra Pinkert Breakdown of academic impact, for papers by J. Michael Stolley Breakdown of academic impact, for papers by Mauro Di Pilato Breakdown of academic impact, for papers by Yukiharu Sawada Breakdown of academic impact, for papers by Jeremy Juang Breakdown of academic impact, for papers by Huaxin Si
Rankless by CCL
2026